Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
Retrieved on:
Tuesday, July 11, 2023
Legal, Research, Public Relations, Investor Relations, Communications, Professional Services, Health, General Health, Other Science, Science, Patent office, Genomics, United States patent law, Harvard College, Harvard University, Bangladesh Technical Education Board, Government, District court, Patent, Fellows, NanoString Technologies, Court, Sąd rejonowy, 10x, NIH, Pharmaceutical industry
In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirmative defense of “unclean hands” by 10x and Harvard.
Key Points:
- In its order, the Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirmative defense of “unclean hands” by 10x and Harvard.
- On June 6, the Delaware District Court issued an order granting NanoString’s motion for expedited discovery related to the NIH grant documents.
- On July 10, the Delaware District Court granted NanoString’s motion to add new counterclaims for antitrust and unfair competition violations as well as the affirmative defense of unclean hands by 10x and Harvard.
- Furthermore, 10x and Harvard deliberately did not produce the NIH grant documents to NanoString during document discovery, despite requests by NanoString.